363 related articles for article (PubMed ID: 34076419)
1. An Advanced
Chan MH; Chen W; Li CH; Fang CY; Chang YC; Wei DH; Liu RS; Hsiao M
ACS Appl Mater Interfaces; 2021 Jun; 13(23):26759-26769. PubMed ID: 34076419
[TBL] [Abstract][Full Text] [Related]
2. Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles.
Norouzi M; Yathindranath V; Thliveris JA; Kopec BM; Siahaan TJ; Miller DW
Sci Rep; 2020 Jul; 10(1):11292. PubMed ID: 32647151
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of blood-brain barrier-stealth nanocomposites for in situ glioblastoma theranostics applications.
Su CH; Tsai CY; Tomanek B; Chen WY; Cheng FY
Nanoscale; 2016 Apr; 8(15):7866-70. PubMed ID: 27035391
[TBL] [Abstract][Full Text] [Related]
4. 'Dendrimer-Cationized-Albumin' encrusted polymeric nanoparticle improves BBB penetration and anticancer activity of doxorubicin.
Muniswamy VJ; Raval N; Gondaliya P; Tambe V; Kalia K; Tekade RK
Int J Pharm; 2019 Jan; 555():77-99. PubMed ID: 30448308
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of doxorubicin in glioblastoma multiforme following ultrasound-Induced blood-brain barrier disruption as determined by microdialysis.
Lin YL; Wu MT; Yang FY
J Pharm Biomed Anal; 2018 Feb; 149():482-487. PubMed ID: 29175555
[TBL] [Abstract][Full Text] [Related]
6. Focused ultrasound and interleukin-4 receptor-targeted liposomal doxorubicin for enhanced targeted drug delivery and antitumor effect in glioblastoma multiforme.
Yang FY; Wong TT; Teng MC; Liu RS; Lu M; Liang HF; Wei MC
J Control Release; 2012 Jun; 160(3):652-8. PubMed ID: 22405901
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of prostate cancer growth using doxorubicin assisted by ultrasound-targeted nanobubble destruction.
Fan X; Wang L; Guo Y; Xiong X; Zhu L; Fang K
Int J Nanomedicine; 2016; 11():3585-96. PubMed ID: 27536100
[TBL] [Abstract][Full Text] [Related]
8. Co-delivery of doxorubicin and erlotinib through liposomal nanoparticles for glioblastoma tumor regression using an in vitro brain tumor model.
Lakkadwala S; Singh J
Colloids Surf B Biointerfaces; 2019 Jan; 173():27-35. PubMed ID: 30261346
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin nanobubble for combining ultrasonography and targeted chemotherapy of rabbit with VX2 liver tumor.
Meng M; Gao J; Wu C; Zhou X; Zang X; Lin X; Liu H; Wang C; Su H; Liu K; Wang Y; Xue X; Wu J
Tumour Biol; 2016 Jul; 37(7):8673-80. PubMed ID: 26738862
[TBL] [Abstract][Full Text] [Related]
10. VEGF-mediated tight junctions pathological fenestration enhances doxorubicin-loaded glycolipid-like nanoparticles traversing BBB for glioblastoma-targeting therapy.
Wen L; Tan Y; Dai S; Zhu Y; Meng T; Yang X; Liu Y; Liu X; Yuan H; Hu F
Drug Deliv; 2017 Nov; 24(1):1843-1855. PubMed ID: 29182025
[TBL] [Abstract][Full Text] [Related]
11. Solid lipid nanoparticles for potential doxorubicin delivery in glioblastoma treatment: preliminary in vitro studies.
Battaglia L; Gallarate M; Peira E; Chirio D; Muntoni E; Biasibetti E; Capucchio MT; Valazza A; Panciani PP; Lanotte M; Schiffer D; Annovazzi L; Caldera V; Mellai M; Riganti C
J Pharm Sci; 2014 Jul; 103(7):2157-2165. PubMed ID: 24824141
[TBL] [Abstract][Full Text] [Related]
12. Temporary blood-brain barrier disruption by low intensity pulsed ultrasound increases carboplatin delivery and efficacy in preclinical models of glioblastoma.
Dréan A; Lemaire N; Bouchoux G; Goldwirt L; Canney M; Goli L; Bouzidi A; Schmitt C; Guehennec J; Verreault M; Sanson M; Delattre JY; Mokhtari K; Sottilini F; Carpentier A; Idbaih A
J Neurooncol; 2019 Aug; 144(1):33-41. PubMed ID: 31197598
[TBL] [Abstract][Full Text] [Related]
13. Efficient antiglioblastoma therapy in mice through doxorubicin-loaded nanomicelles modified using a novel brain-targeted RVG-15 peptide.
Han M; Xing H; Chen L; Cui M; Zhang Y; Qi L; Jin M; Yang Y; Gao C; Gao Z; Xing X; Huang W
J Drug Target; 2021 Nov; 29(9):1016-1028. PubMed ID: 33825602
[TBL] [Abstract][Full Text] [Related]
14. Amphetamine decorated cationic lipid nanoparticles cross the blood-brain barrier: therapeutic promise for combating glioblastoma.
Saha S; Yakati V; Shankar G; Jaggarapu MMCS; Moku G; Madhusudana K; Banerjee R; Ramkrishna S; Srinivas R; Chaudhuri A
J Mater Chem B; 2020 May; 8(19):4318-4330. PubMed ID: 32330214
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Near-Infrared Signal Tracking of the Therapeutic Changes of Glioblastoma Cells in Brain Tissue with Ultrasound-Guided Persistent Luminescent Nanocomposites.
Cheng CL; Chan MH; Feng SJ; Hsiao M; Liu RS
ACS Appl Mater Interfaces; 2021 Feb; 13(5):6099-6108. PubMed ID: 33507729
[TBL] [Abstract][Full Text] [Related]
16. Enhancing Glioblastoma-Specific Penetration by Functionalization of Nanoparticles with an Iron-Mimic Peptide Targeting Transferrin/Transferrin Receptor Complex.
Kang T; Jiang M; Jiang D; Feng X; Yao J; Song Q; Chen H; Gao X; Chen J
Mol Pharm; 2015 Aug; 12(8):2947-61. PubMed ID: 26149889
[TBL] [Abstract][Full Text] [Related]
17. Treating glioblastoma multiforme with selective high-dose liposomal doxorubicin chemotherapy induced by repeated focused ultrasound.
Yang FY; Teng MC; Lu M; Liang HF; Lee YR; Yen CC; Liang ML; Wong TT
Int J Nanomedicine; 2012; 7():965-74. PubMed ID: 22393293
[TBL] [Abstract][Full Text] [Related]
18. Enhanced delivery of paclitaxel liposomes using focused ultrasound with microbubbles for treating nude mice bearing intracranial glioblastoma xenografts.
Shen Y; Pi Z; Yan F; Yeh CK; Zeng X; Diao X; Hu Y; Chen S; Chen X; Zheng H
Int J Nanomedicine; 2017; 12():5613-5629. PubMed ID: 28848341
[TBL] [Abstract][Full Text] [Related]
19. PEGylated FePt@Fe2O3 core-shell magnetic nanoparticles: potential theranostic applications and in vivo toxicity studies.
Liu Y; Yang K; Cheng L; Zhu J; Ma X; Xu H; Li Y; Guo L; Gu H; Liu Z
Nanomedicine; 2013 Oct; 9(7):1077-88. PubMed ID: 23499668
[TBL] [Abstract][Full Text] [Related]
20. Systematic Evaluation of Transferrin-Modified Porous Silicon Nanoparticles for Targeted Delivery of Doxorubicin to Glioblastoma.
Luo M; Lewik G; Ratcliffe JC; Choi CHJ; Mäkilä E; Tong WY; Voelcker NH
ACS Appl Mater Interfaces; 2019 Sep; 11(37):33637-33649. PubMed ID: 31433156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
